Minimax Medical
About Us
Minimax Medical Group is a MedTech group strategically located in China & Europe, and strongly committed to research, manufacture and sales of minimally invasive devices and surgical robot.
Our self-owned minimally invasive products have established strong supply and market presence in key global marketplaces, ranging from oncology, phlebology, proctology and aesthetic dermatology. Particularly in China, we have achieved sales of our self-owned brands and devices under distribution in hundreds of 3A-graded Chinese hospitals, and we are proactively capturing opportunities in 2A-grades across the country. We are now vigorously expanding our international brand identity.
Our History
Acquisition of F Care Systems NV; Angiodynamics’supplier of radio frequency ablation instrument and radio frequency electrode for tumor/nodules on an international level .
2022
High-tech enterprise certificate was obtained.
2018
Awarded as private science and technology enterprise.
2014
2019
CE certificate of radio frequency ablation instrument and radio frequency electrode.
2015
ISO certificate was obtained.
2013
Set up R&D and production facility in Nanjing.
Corporate Culture
R&D
Minimax medical has a high-level R&D team, with more than 20 members in Nanjing R&D Center and 8 members in American R&D Center, Dr. Jay is the chief expert of the American R&D Center and he has rich theoretical and practical experience. We have established long-term strategic partnership with world-renowned medical experts such as Professor Habib of Imperial College London, and cooperate with top professors in China on research projects. Besides, we get access to world’s leading medical technology through participations, holdings and acquisitions in US and Europe.
We have obtained a number of invention patents in China and abroad, through innovative work from our R&D team. And our R&D team would continue with technological exchanges and in-depth cooperation with well-known scientific research agencies and institutions both in China and abroad.
Certification
Market Distribution
